The improved muscles from DM, but not sIBM patients, also showed upregulation of immunoglobulin-related genes and chemokines CXCL9 (Mig) and CXCL11, suggesting a role not only in immunoregulation but also in muscle remodeling and regeneration. Here, CXCL9 is linked to diabetes mellitus.